173 related articles for article (PubMed ID: 38509460)
1. Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults.
Chen J; Lin J; Weng J; Ju Y; Li Y
BMC Infect Dis; 2024 Mar; 24(1):330. PubMed ID: 38509460
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: A retrospective cohort study.
Lacave G; Caille V; Bruneel F; Palette C; Legriel S; Grimaldi D; Eurin M; Bedos JP
Medicine (Baltimore); 2017 Feb; 96(7):e6023. PubMed ID: 28207512
[TBL] [Abstract][Full Text] [Related]
3. Effect of First Trough Vancomycin Concentration on the Occurrence of AKI in Critically Ill Patients: A Retrospective Study of the MIMIC-IV Database.
Li L; Zhang L; Li S; Xu F; Li L; Li S; Lyu J; Yin H
Front Med (Lausanne); 2022; 9():879861. PubMed ID: 35492325
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-associated acute kidney injury in Hong Kong in 2012-2016.
Qin X; Tsoi MF; Zhao X; Zhang L; Qi Z; Cheung BMY
BMC Nephrol; 2020 Feb; 21(1):41. PubMed ID: 32013870
[TBL] [Abstract][Full Text] [Related]
5. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-Associated Acute Kidney Injury in Critically Ill Adolescent and Young Adult Patients.
Hays WB; Tillman E
J Pharm Pract; 2020 Dec; 33(6):749-753. PubMed ID: 30808269
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
Molina KC; Barletta JF; Hall ST; Yazdani C; Huang V
J Intensive Care Med; 2020 Dec; 35(12):1434-1438. PubMed ID: 30741072
[TBL] [Abstract][Full Text] [Related]
10. An evaluation on the association of vancomycin trough concentration with mortality in critically ill patients: A multicenter retrospective study.
Ren J; Hou Y; Li J; Gao Y; Li R; Jin X; Zhang J; Wang X; Wang G
Clin Transl Sci; 2021 Sep; 14(5):1780-1790. PubMed ID: 33835715
[TBL] [Abstract][Full Text] [Related]
11. Attributable nephrotoxicity of vancomycin in critically ill patients: a marginal structural model study.
Arnaud FCS; Libório AB
J Antimicrob Chemother; 2020 Apr; 75(4):1031-1037. PubMed ID: 31904834
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
Moffett BS; Hilvers PS; Dinh K; Arikan AA; Checchia P; Bronicki R
Congenit Heart Dis; 2015; 10(1):E6-10. PubMed ID: 24934335
[TBL] [Abstract][Full Text] [Related]
13. Acute kidney injury during vancomycin therapy in critically ill children.
Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
Pan K; Ma L; Xiang Q; Li X; Li H; Zhou Y; Yang L; Cui Y
PLoS One; 2017; 12(4):e0175688. PubMed ID: 28426688
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with vancomycin nephrotoxicity in the critically ill.
Hanrahan TP; Kotapati C; Roberts MJ; Rowland J; Lipman J; Roberts JA; Udy A
Anaesth Intensive Care; 2015 Sep; 43(5):594-9. PubMed ID: 26310409
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Mean Vancomycin Trough Concentration and Mortality in Critically Ill Patients: A Multicenter Retrospective Study.
Hou Y; Ren J; Li J; Jin X; Gao Y; Li R; Zhang J; Wang X; Li X; Wang G
Front Pharmacol; 2021; 12():690157. PubMed ID: 34349650
[No Abstract] [Full Text] [Related]
18. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A
J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689
[TBL] [Abstract][Full Text] [Related]
19. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
[TBL] [Abstract][Full Text] [Related]
20. Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
Okada N; Chuma M; Azuma M; Nakamura S; Miki H; Hamano H; Goda M; Takechi K; Zamami Y; Abe M; Ishizawa K
Eur J Clin Pharmacol; 2019 Dec; 75(12):1695-1704. PubMed ID: 31511938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
